Calibration of myocardial T2 and T1 against iron concentration. by Carpenter, JP et al.
Carpenter et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:62
http://jcmr-online.com/content/16/1/62RESEARCH Open AccessCalibration of myocardial T2 and T1 against iron
concentration
John-Paul Carpenter1,2†, Taigang He1,2†, Paul Kirk1,2, Michael Roughton1,4, Lisa J Anderson3, Sofia V de Noronha1,
A John Baksi1,2, Mary N Sheppard1, John B Porter4, J Malcolm Walker4, John C Wood5, Gianluca Forni6,
Gualtiero Catani7, Gildo Matta7, Suthat Fucharoen8, Adam Fleming9, Mike House9, Greg Black9, David N Firmin1,
Timothy G St. Pierre9 and Dudley J Pennell1,2*Abstract
Background: The assessment of myocardial iron using T2* cardiovascular magnetic resonance (CMR) has been
validated and calibrated, and is in clinical use. However, there is very limited data assessing the relaxation
parameters T1 and T2 for measurement of human myocardial iron.
Methods: Twelve hearts were examined from transfusion-dependent patients: 11 with end-stage heart failure, either
following death (n = 7) or cardiac transplantation (n = 4), and 1 heart from a patient who died from a stroke with
no cardiac iron loading. Ex-vivo R1 and R2 measurements (R1 = 1/T1 and R2 = 1/T2) at 1.5 Tesla were compared
with myocardial iron concentration measured using inductively coupled plasma atomic emission spectroscopy.
Results: From a single myocardial slice in formalin which was repeatedly examined, a modest decrease in T2 was
observed with time, from mean (±SD) 23.7 ± 0.93 ms at baseline (13 days after death and formalin fixation) to
18.5 ± 1.41 ms at day 566 (p < 0.001). Raw T2 values were therefore adjusted to correct for this fall over time.
Myocardial R2 was correlated with iron concentration [Fe] (R2 0.566, p < 0.001), but the correlation was stronger
between LnR2 and Ln[Fe] (R2 0.790, p < 0.001). The relation was [Fe] = 5081•(T2)-2.22 between T2 (ms) and
myocardial iron (mg/g dry weight). Analysis of T1 proved challenging with a dichotomous distribution of T1, with
very short T1 (mean 72.3 ± 25.8 ms) that was independent of iron concentration in all hearts stored in formalin for
greater than 12 months. In the remaining hearts stored for <10 weeks prior to scanning, LnR1 and iron
concentration were correlated but with marked scatter (R2 0.517, p < 0.001). A linear relationship was present
between T1 and T2 in the hearts stored for a short period (R2 0.657, p < 0.001).
Conclusion: Myocardial T2 correlates well with myocardial iron concentration, which raises the possibility that T2
may provide additive information to T2* for patients with myocardial siderosis. However, ex-vivo T1 measurements
are less reliable due to the severe chemical effects of formalin on T1 shortening, and therefore T1 calibration may
only be practical from in-vivo human studies.
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Early detection of cardiac iron is of key importance in
the management of patients with transfusion-dependent
anaemias, such as beta thalassaemia major (TM). Car-
diac siderosis can lead to myocardial dysfunction, heart
failure and early death, but it is preventable and poten-
tially reversible with modern chelation regimes [1,2].
Prior to the use of Cardiovascular Magnetic Resonance
(CMR), it was difficult to identify myocardial iron over-
load in the pre-clinical phase as measures of body iron
loading correlate poorly with myocardial iron [3], and
identification of ventricular dysfunction as a clinical
expression of cardiac siderosis is usually only late after
severe myocardial iron overload is established [4]. T2*
CMR has proved to be the most reliable, reproducible
and clinically viable method of measuring myocardial
iron loading [5–7], with values calibrated to myocardial
iron [8], and predictive of cardiac complications [9].
There is evidence that T2* is superior to other clinical
indices (including serum ferritin, liver iron, ventricular
ejection fraction, tissue Doppler echocardiographic pa-
rameters and endomyocardial biopsy) [4,10–14] and
routine application of this technique has been associ-
ated with a substantial reduction in deaths from heart
failure [15,16].
In the same way that T2* is affected by particulate
intracellular iron, the relaxation parameters T2 and T1
are also shortened due to local inhomogeneity in the
magnetic field, which causes faster proton dephasing
[17]. In the liver, T2 techniques allow accurate assess-
ment of iron loading as well as giving an impression of
the degree of hepatic fibrosis present [18,19]. In the
heart, there has been recent interest in general applica-
tion of T1 and T2 mapping techniques [20,21], however
there remains very limited data in the human heart re-
garding the relation between T1 or T2 and cardiac iron
concentration. To extend our knowledge of the effects
of myocardial iron on MR relaxation parameters, we
measured both T1 and T2 and compared the findings to
biochemically derived tissue iron concentration.
Methods
Study patients
This study forms part of a project designed to validate
CMR measurement of cardiac iron. Five international
centres were involved in recruitment: University College
Hospital (London, UK), Ospedale Galleria (Genoa, Italy),
The Children’s Hospital of Los Angeles (California, USA),
Ospedale Regionale Microcitemie (Cagliari, Italy) and
Mahidol University (Bangkok, Thailand). In total, 12 whole
human hearts were donated for research. These were ob-
tained from patients with transfusion-dependent anaemia
either post-mortem or following cardiac transplantationfor end-stage heart failure. The study protocol was
approved by the Royal Brompton Hospital research
ethics committees. Local consent was obtained in all
cases.
Study protocol
All of the hearts were preserved in formalin. All hearts
were cut into 1 cm thick slices in the short axis of the
ventricles (Figure 1). The most apical slice was not in-
cluded in the analysis due to the variation in thickness
which could have affected T1 and T2 measurement
through partial volume effects. All short axis slices were
scanned using a 1.5 Tesla MR scanner (Sonata, Siemens
Medical Systems, Germany). Each slice was mounted be-
tween two Perspex sheets, immersed in water and scanned
using a 4-element phased-array coil. Slices were maintained
at a constant 37°C throughout.
For T1 measurement, a series of inversion recovery
T1 images was acquired with a range of inversion times
(64, 128, 256, 512, 1020, 2040, 4100 and 10000 ms), slice
thickness 5 mm, flip angle 90°, matrix 128×128 pixels,
sampling bandwidth 230 Hz/pixel (Figure 2A). For T2
measurement, a series of equally spaced 180° refocusing
pulses were used to generate a train of spin echoes (with
16 echo times (TEs) from 4.8 to 76.8 ms). This multiecho
fast spin echo T2 sequence had the following parameters:
Slice thickness 5 mm, flip angle 90°, matrix 128×128
pixels, sampling bandwidth 780 Hz/pixel (Figure 2B). Both
sequences were designed to address different ranges of
iron loading. Each myocardial slice was scanned in the
same orientation to ensure reliable identification of
anatomy and wall segmentation for co-localization of
decay parameters and iron concentration.
To determine the regions of interest (ROIs) for measure-
ment of T2 and T1, a series of steps were performed as fol-
lows. First, endocardial and epicardial borders were drawn
for the left ventricle (LV). Then, each myocardial slice was
divided into 18 ROIs comprised of outer (epicardial), inner
(endocardial) and intermediate (mesocardial) layers in 6
equal radial sectors. The septum was delineated by the
attachment of the right ventricular (RV) wall to the LV
[22]. T2 was measured from each of the ROIs individu-
ally using software specifically designed to quantify signal
intensity decay (Thalassaemia-Tools, Cardiovascular
Imaging Solutions, London). Where necessary, curve trun-
cation was used to correct for background noise (Figure 2B)
[23]. A monoexponential decay curve was fitted using
the following equation (where SI is signal intensity, SI0
is signal intensity at time zero and TE is the echo time):
SI ¼ Si0 ⋅ e− TE=T2ð Þ
Analysis of T1 required correction of the phase
prior to curve fitting. A T1 recovery curve was then
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Figure 1 Experimental setup. A. Gross specimen showing 1 cm
myocardial slices from base to apex. B. Mid-myocardial cut slice
showing tissue samples. C. Scan image with regions of interest used
to measure T2 prior to sectioning.
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using a least squares fit (Figure 2A). The signal inten-
sity (SI) at each inversion time is given by the following
equation (where TI is the inversion time, M0 is themagnetisation and C is a constant representing noise
and artefact:
SI TIð Þ ¼ M0 1−2⋅e− TI=T1ð Þ
h i
þ C
Any ROIs which contained artefact with the potential
to affect T1 or T2 measurement were excluded from the
analysis before the measurement was performed.
Effect of formalin on relaxation
To assess the effect of time in formalin on the relaxation
values, a single myocardial slice was scanned at repeated
intervals up to 566 days, with measurements in all 18
ROIs at each time point.
Myocardial iron measurement
After scanning, each short axis LV slice was divided into
18 tissue samples for measurement of iron concentra-
tion. Care was taken to ensure that the sections corre-
sponded as closely as possible to the ROIs used for T2
and T1 measurements: 6 sectors of 60° each, subdivided
into 3 transmural layers. Once the wet weight had been
recorded, the myocardial tissue blocks were freeze dried
in a Virtis type lyophiliser (SP Industries, Inc) for a mini-
mum of 72 hours. Dry weight was recorded immediately
after removal from the lyophiliser. Specimens were then
placed into plastic digestion flasks along with 10 mL of
10 M nitric acid (HNO3) and heated at 60°C for 3 hours
on an Environmental Express™ Hot block. Further heat-
ing at 90°C for 3 hours was required before removal to a
bench to cool for 30 minutes. Addition of 5 mL hydro-
gen peroxide (H2O2) was made at room temperature
and the solution was then left for an hour to allow bub-
bling to subside. Samples were returned to the heating
block at 60°C and allowed to evaporate until nearly dry.
Solutions were prepared for iron measurement by add-
ing reverse osmosis purified water to bring the total vol-
ume to 30 mL. Iron measurement was performed using
inductively coupled plasma atomic emission spectros-
copy (ICP-AES). Samples of NIST human liver standard
4352 were used as quality controls for the ICP-AES
analysis.
Statistics
The reciprocals of T1 and T2 (R1 and R2) were com-
pared with tissue iron concentration, in common with
previous reports of ex-vivo data [8]. Curve fitting was
performed by modelling using both linear and non-
linear regression algorithms of raw and log data to deter-
mine the best fit. The coefficient of variation for T1 and
T2 was calculated independently for each heart. All data
were analysed using STATA version 10.1 (StataCorp,
Texas, USA). A value of P < 0.05 was used to define a
significant difference.
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Figure 2 T1 and T2 measurement. T1 and T2 images of the same
mid ventricular slice are shown. A. T1 recovery. Following a 180°
inversion pulse, magnetisation recovers to its original value and
different myocardial signal intensities are seen in the images taken
at a range of inversion times from 64 ms to 10 seconds (the latter is
used to allow magnetisation to fully recover). Myocardial signal is
initially negative, recovering through the zero point (where the
myocardium appears black) back to its maximal intensity. A least-squares
fit allows the calculation of T1, defined as the time taken for
magnetisation to recover 63% of its original value. B. T2 images
showing the initial high myocardial signal which decays over time
and the corresponding mono-exponential decay curve of signal
intensity plotted against echo time used to calculate T2. The final
eight points of the curve have been truncated to allow for
background noise.
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Patient details
A total of 12 hearts were donated for this study, with 11
of the hearts from patients who had either died (n = 7)
or had undergone cardiac transplantation (n = 4) for
end-stage heart failure. The remaining patient had re-
quired lifelong transfusions for beta thalassaemia major
but died aged 46 from an ischaemic stroke with no prior
cardiac complications, apart from a single short-lived
episode of atrial fibrillation at the age of 21. A summary
of the clinical information is given in Table 1.
Comparison of ex-vivo CMR imaging parameters with tis-
sue iron
For 11 of the 12 hearts, mean myocardial iron concen-
tration ranged from 0.38 to 9.5 mg/g dw. One of the
hearts was an extreme outlier with a very high level of
iron loading. The mean myocardial iron in this heart
was 25.9 ± 10.3 mg/g, with iron concentrations of up to
100 times the upper limit of normal. The T1 and T2 se-
quences acquired from this outlier heart suffered from
substantial image artefact caused by the sectioning per-
formed at the time of autopsy prior to scanning. Due to
difficulty in analysis caused by these artefacts, we con-
sidered both T2 and T1 measurements to be unreliable
and therefore excluded this heart from the correlation
for both parameters. For measurement of T2 and T1,
934 ROIs and their corresponding tissue blocks were
used. Some of the remaining hearts had been cut longi-
tudinally at the time of autopsy prior to scanning leading
to image artefact at the cut surfaces and as a result, 41
(4.4%) ROIs were excluded from the T2 analysis and 106
(11.3%) ROIs were excluded from the T1 analysis.
T1 measurement
Analysis of T1 proved challenging, with a dichotomous
distribution of T1 values. Six of the 11 analysed hearts
were found to have extremely short T1 with very little
variation between hearts. The mean ± SD T1 value recorded
Table 1 Patient details, cardiac iron concentration and summary of CMR measurements
Patient Sex Diagnosis Death or cardiac
transplantation
Age at death or
transplantation
Cause of death
or indication
for transplant
LV [Fe]
[mg/g dw]
(mean ± SD)
Global myocardial
T1 [ms] (mean± SD)
Variability
of T1
(CoV%)
Global
myocardial
T2 [ms]
(mean± SD)
Variability of
T2 (CoV%)
Total estimated
units transfused
Global
myocardial T2*
[ms] (mean ± SD)
1 M TM Death 46 Ischemic stroke
(no cardiac failure)
0.38 ± 0.13 351.4 ± 37.2 10.6 72.7 ± 7.5 10.3 1584 44.4 ± 5.3
2 F SA Death 62 Cardiac failure 8.20 ± 1.44 246.1 ± 37.7 16.0 18.6 ± 2.0 12.3 2000 4.7 ± 0.6
3 M TM Death* 10 Cardiac failure 9.50 ± 1.88 93.0 ± 28.4 30.5 14.5 ± 1.3 8.9 170 3.7 ± 0.6
4 F TM Death† 15 Cardiac failure 25.9 ± 10.3 - - - - 288 2.0 ± 0.4
5 F TM Death 20 Cardiac failure 7.74 ± 1.51 80.1 ± 26.0 32.5 18.2 ± 2.4 12.9 432 3.6 ± 0.5
6 M TM Transplant 23 Cardiac failure 3.63 ± 0.82 52.3 ± 13.6 26.1 20.3 ± 1.8 9.0 765 8.0 ± 1.0
7 M TM Transplant 24 Cardiac failure 3.38 ± 0.53 68.9 ± 21.8 31.5 21.9 ± 2.7 12.2 528 7.7 ± 1.2
8 M TM Transplant 21 Cardiac failure 5.87 ± 1.0 70.4 ± 20.1 28.6 17.6 ± 2.1 11.7 500 4.4 ± 0.6
9 F TM Transplant 31 Cardiac failure 8.78 ± 1.88 68.0 ± 27.1 39.8 13.5 ± 1.9 14.3 624 3.9 ± 0.6
10 M TM Death 24 Cardiac failure &
mucormycosis
5.64 ± 1.36 247.2 ± 23.7 9.6 24.7 ± 2.5 10.0 660 5.8 ± 1.4
11 M TM Death 44 Cardiac failure 3.19 ± 1.02 305.3 ± 28.0 9.0 43.3 ± 5.0 11.4 1209 12.3 ± 2.6
12 M DBA Death 22 Cardiac failure &
pneumonia
3.91 ± 0.86 206.4 ± 26.9 9.5 26.8 ± 3.5 12.7 442 8.8 ± 1.8
T2 values are time-corrected as described in the text. SD = standard deviation, LV = left ventricle, [Fe] = myocardial iron concentration, TM = Beta thalassaemia major, SA = Sideroblastic anaemia, DBA = Diamond Blackfan
anaemia, N/A = not applicable (patients 3 and 4 did not receive iron chelation therapy: *died 1964; †died 1972). Note hearts 3 – 9 were all stored in formalin for over a year prior to scanning. For comparison, global
T2* values are shown in the right-hand column.
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of tissue iron concentration. This very short T1 recovery
was only found in hearts which had been stored in forma-
lin for over a year (heart 3, 5, 6, 7, 8, 9). In the remaining
5 hearts which had been stored for a much shorter dur-
ation (less than 10 weeks) prior to scanning, comparison
of R1 and tissue iron revealed a positive correlation but
with significant scatter (R2 0.338, p <0.001). The plot of
LnR1 vs Ln[Fe] revealed a stronger correlation (R2 0.517,
p < 0.001) with a slope of 0.13 [95% CI: 0.12–0.14] and
intercept of 1.19 [95% CI: 1.17–1.21] (Figure 3A). The rep-
resentation of this relation on the data scatterplot in linear
space is shown in Figure 3B.Effect of time in formalin on relaxation
For the single myocardial slice which was examined re-
peatedly, there was a modest exponential decrease in T2
over time (Figure 4). Mean (±SD) T2 at baseline (first
measured 13 days after death and formalin fixation) was
23.7 ± 0.93 ms. At day 566, mean T2 was 18.5 ± 1.41 ms
(−21.9%, p < 0.001). Using an exponential decay model,
the effect on T2 measurement in terms of percentage
change with time stored in formalin can be expressed by
the following equation: Reduction in T2 value over time
(%) = 100 - exp(4.64-0.043*ln(t)) where t = time in days.
Only T2 (and not T1) measurements were performed on
a repeated basis in view of the unexpectedly low T1
values identified.Figure 3 R1 and iron concentration. A. LnR1 plotted against Ln
[Fe]. The solid line shows the best fit linear correlation for the log
data. B. R1 plotted against [Fe]. The solid line represents the
correlation derived from the log data shown in A. The dashed lines
represent the upper and lower 95% confidence intervals. Note that
these data are for the 5 hearts stored for less than 10 weeks and not
all the hearts studied.T2 measurement
In view of the change in T2 over time and the fact that
different hearts had been stored for varying times in for-
malin, it was deemed necessary to take this into consid-
eration. Therefore, a correction factor was applied to the
raw T2 data based on the exponential decay curve from
the single stored sample of myocardium as described
above. Corrected T2 values were converted to R2 for
comparison with [Fe] (Figure 5). Using mean time-
corrected R2 for each of the 11 hearts plotted against
the mean myocardial iron concentration, a straight line
initially appeared a reasonable fit (R2 0.786, p = 0.001,
Figure 5A). When all time-corrected R2 and iron mea-
surements from all samples were considered (n = 893),
the strongest linear correlation was found by plotting Ln
(time-corrected R2) versus Ln[Fe] (R2 0.790, p < 0.001)
giving a slope of 0.45 [95% CI: 0.44–0.47] and intercept
of 3.06 [95% CI: 3.04–3.09] (Figure 5B). The representa-
tion of this relation on the data scatterplot in linear space
is shown in Figure 5C. Other analysis models gave less
favourable results for correlation coefficient, including
simple linear regression (R2 0.566), and a power function
non-linear fit (R2 0.593). From the time-corrected log
data, the relation between R2, T2 and myocardial iron(mg/g dw) can be expressed by the following equation
(where R2 is in s−1 and T2 is in ms):
Fe½  ¼ 0:0011 R2ð Þ2:22 and Fe½  ¼ 5081 T2ð Þ‐2:22
Relation between T2 and T1
A direct comparison of time-corrected T2 and T1 mea-
surements was made for the 5 hearts which had been
Figure 4 Change in T2 with time in formalin. T2 measurements plotted against time for a single myocardial slice scanned repeatedly showing
a modest fall in T2 with time in formalin. Error bars are ± SD.
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ear relation (R2 0.657, p < 0.001) (Figure 6).
Discussion
These findings provide new insight into the effects of
iron on myocardial MR relaxation parameters. The nor-
mal range for iron concentration in myocardial tissue is
0.29-0.47 mg/g dry weight [24], and the hearts included
in this study have afforded the first opportunity to study
myocardial iron loading effects on the MR relaxation pa-
rameters R2 and R1 over a wide range from the normal
range up to fatal iron levels. The results show a strong
relationship between R2 and iron, which is best fitted in
our study by a non-linear logarithmic relation. The myo-
cardial curve in this study (Figure 5C) is flatter than that
seen for R2 in the liver [18], indicating that using the
liver relation could overestimate myocardial iron. The
results for R1 were markedly affected by the duration of
specimen storage in formalin, and for all hearts which
had been fixed >10 weeks, all R1 variation in relation to
myocardial iron was lost. In the hearts fixed for a short
period of <10 weeks, the R1 varied with myocardial iron
concentration, although this relation was weaker than
that observed with R2. Once again, a logarithmic rela-
tion best fitted the data for R1, but this would not ap-
pear to be clinically useful due to the substantial data
scatter and shallow slope. There are potential clinical ap-
plications for the measurement of T2 which remain tobe explored, including whether differences in the values
of T2* and T2 might yield information about chemical
speciation of iron deposits that may have a bearing on
iron chelation treatment, and whether T2 might have
application in iron mis-handling compartment condi-
tions such as Friedreich’s ataxia [25].
Our data on R2 are in broad accord with limited previ-
ous data from other groups [26]. In a single post-mortem
human heart from a patient with beta-thalassemia major,
Ghugre showed that T2 was well correlated at 1.5 T with
myocardial iron concentration [26], but our current re-
sults cover a much greater range of iron concentrations.
An in-vivo human study by Mavrogeni showed different
T2 values between normal and iron loaded groups using a
qualitative assessment of cardiac biopsy iron [27], but this
was at 0.5 T which yields different T2 values to 1.5 T and
this field strength is not used clinically to assess iron
levels. In a gerbil model of siderotic cardiomyopathy, both
T1 and T2 were related to myocardial iron concentration,
with greater variability in T1 measurements than T2 [17].
As already mentioned, when compared with R2 and iron
measured in human liver biopsy samples [18,19,28] our
curve appears flatter, but this is consistent with the find-
ings observed in this gerbil model and may reflect the
higher water content of myocardium when samples are
compared on a dry-weight basis [17].
Despite this observed correlation between myocardial
iron concentration and R2, in-vivo measurement can be
Figure 5 (See legend on next page.)
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(See figure on previous page.)
Figure 5 R2 and iron concentration. A. Mean time-corrected R2 plotted against mean iron concentration for each whole heart analysed
(n = 11). The solid line denotes the linear regression line. Error bars are ± SD. B. Ln(time-corrected R2) plotted against Ln[Fe] for all myocardial
tissue samples (n = 893) with the best fit linear regression line. C. Time-corrected R2 values plotted against [Fe] in all samples (n = 893). The solid
black line is the correlation line derived from the logged data. The dashed lines represent the upper and lower 95% confidence intervals.
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[17,26]. Recently, a novel CMR method for measuring
T2 in the human heart has been developed which gives
reproducible results [29,30], and therefore in-vivo
comparison of the relative merits of T2 and T2* mea-
surements is now clinically viable. The situation for R1
measurement is different however. T1-weighted images
have previously been used to derive the signal intensity ra-
tio (SIR) between the myocardium and skeletal muscle,
but this technique has many potential pitfalls and does
not measure T1 decay [31]. The normal expected value
for T1 in human hearts has been determined [32], but
there is very little data on the relationship between T1 and
cardiac iron in transfusion dependent patients, and no
previous studies have attempted to provide a formal valid-
ation for T1, or correlate T1 with tissue iron in human
hearts. It remains uncertain therefore whether T1 mea-
surements in TM may have clinical utility, and further
insight will need to come from in-vivo studies. From the
current study, the measured values for T1 even in the
hearts which had been stored for only a short time in for-
malin are markedly lower than those measured in patientsFigure 6 Comparison of T2 and T1. T1 plotted against time-corrected T2
formalin for <10 weeks. The linear regression line is shown.[33], and cannot therefore be extrapolated to provide a
useful clinical index of iron loading (whether or not this
difference is related to the effects of formalin or to differ-
ences in the T1 sequences used).
Issues affecting calibration
The major challenge in providing a definitive calibration
for T2 or T1 is correcting for differences which exist be-
tween in-vivo and ex-vivo magnetic resonance relaxometry
measurements. It is important to account for temperature
dependence as all the relaxation parameters (T1, T2 and
T2*) show a positive relationship with temperature [34].
Phantom studies have revealed that T2* can change by up
to 1.5% per degree Celsius [35]. For this reason, in the
current study, all of the hearts were scanned at a constant
37°C and, with this methodology, we have previously
shown that there is very little difference between in-vivo
and ex-vivo T2* values [8]. An additional consideration is
that artefact affects T2* measurements in-vivo, but this is
less of a problem with T1 and T2. For T2*, susceptibility
artefacts are often seen at the myocardial-lung interface,
in the inferior wall due to heavy iron loading in the liver,in the myocardial samples from the 5 hearts which were stored in
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ventricular groove containing deoxygenated blood. Al-
though blood oxygenation level affects T2* in vivo, T1 and
T2 are less affected and in any case, this is unlikely to
affect post-mortem T1 or T2 values [36].
The non iron-loaded heart in the current study had a
mean ± SD T1 value of 351.4 ± 37.2 and a mean T2 value
of 63.4 ± 6.5 ms. Normal myocardial T1 measured in vivo
is much higher, in the order of 1100 ms [37]. A previous
study looking at T1 of formalin fixed infarcted myocar-
dium stored for between 1 and 9 years, found signifi-
cantly shorter T1 values with a T1 of 272 ± 163 ms in
non-infarcted tissue and 459 ± 266 ms in infarct tissue
[38]. Some previous evidence suggests that while organ
iron concentration is lower after fixation in formalin or
histological processing, the difference is not significant
[39,40]. In comparison, immersion in saline causes a sig-
nificant drop in tissue iron levels with up to 50% lost in
the first hour [41]. Although very little iron is lost from
cardiac tissue stored in formalin after the first 60 days
[42], there appears to be a marked change in the T1
properties of our stored samples with prolonged storage.
The fact that a very short T1 (independent of iron con-
centration) was found in all the hearts which had been
stored in formalin for greater than a year, suggests that
the T1 shortening effect was likely to be due to the ef-
fects of formalin, but the precise reasons for this remain
unclear. T2 in formalin-fixed myocardium is less affected
but is also slightly shorter than the normal in-vivo level
(which is around 70 ms) [38,43].
The ideal fixative agent would not alter the biological,
physical or paramagnetic properties of the tissue con-
cerned. Formalin, however, causes initial shrinkage followed
by swelling of cells over the first hour, which then return
to their original size. There is rapid hardening of tissues
and also loss of water. T1 is highly dependent on the water
content of the tissue, and thus T1 falls following fixation
[44], however the relationship between T2 and water
content does not have the same predictable effect [34].
Formalin molecules may form covalent and ionic bonds
within tissues, predominantly with amino groups. Thus,
as changes in structure and proton mobility occur to-
gether with dehydration and denaturation of proteins,
proton relaxivity is affected with consequent changes in
T1 and T2 [45]. Initial changes in T1 seem to occur
more quickly in some tissues than in others, possibly
due to the effects on phospholipid structure [46]. There
is conflicting data in rat liver and spleen samples, where
a significant decrease in T1 but initial elevation in T2
has been observed following fixation [47]. Mathematical
modelling has been used to assess changes in T1 and T2
in the human brain after formalin fixation [48]. Relax-
ation maps confirm progressive T1 and T2 shortening
with time and findings from this model suggest that thebrain is not completely saturated in formalin until after
14.8 weeks of immersion. Changes in T1 and T2 are not
complete until after 5.4 weeks, although the effects on
fixed myocardial tissue may take longer. The chemical
form of iron however, appears to remain constant. Mössbauer
spectra of freeze-dried tissue in human spleen, liver and pan-
creas samples reveal no evidence of chemical transformation
of iron after immersion in formalin for 200 days [42].
For splenic tissue, the ratio between heme iron and
non-heme iron has been observed to differ between
fresh and formalin-fixed samples, but this finding was
considered to represent inhomogeneity of iron loading
within the spleen itself rather than a true alteration in
chemical form [42].
Limitations
The main limitation of this study is the relative change
in T2 and T1 following formalin fixation. This is discussed
above, but dominantly affects T1 values. None of the pa-
tients underwent T2 or T1 measurement pre-mortem and
T1 values were not measured over time. Therefore, we
cannot confirm whether there are significant changes in
T2 or T1 post-mortem following formalin fixation com-
pared to their pre-mortem values. Notwithstanding this,
the T2 in the non iron-loaded heart compares well with
the expected in vivo value, and although T2 is observed to
change over time, the effect is modest. With sequences
which use a train of echoes to measure T2 (Carr-Purcell-
Meiboom-Gill sequences), the T2 value is dependent on
the inter-echo spacing and the derived T2 may be higher
than that measured using single spin-echo sequences [49].
This effect should not be as pronounced with the fast spin
echo technique we have used. Unfortunately, the difficulty
with measurement of T1 means that we have not been
able to produce a meaningful calibration for this param-
eter. As this study has taken many years to complete, it is
unlikely to be easily repeated in whole human hearts, es-
pecially as the survival of patients with beta thalassaemia
is constantly improving and hence transplant or autopsy
heart specimens will become less frequently available.
Also, we do not have the opportunity to go back and
rescan, as the technique for measurement of tissue iron
is fully destructive. There is likely to be an imperfect
match between the ROIs and the cuts made for the tis-
sue iron samples which could affect T1 and T2 but we
have tried to minimise this as far as possible.
Conclusions
Myocardial T2 correlates well with tissue iron concentra-
tion with a logarithmic function for best fit. The T2 mea-
sured in the non-iron loaded formalin fixed heart
compared well with the expected T2 value of normal myo-
cardium in vivo. Further work should establish whether
the measurement of myocardial T2 may provide additive
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in particular with regard to iron chemical speciation, and
iron mishandling conditions. By contrast, ex-vivo T1
measurements are not reliable and further work will be
required before a calibration for T1 and heart iron con-
centration can be produced, which takes into account
the limitations identified in the current study. An alter-
native approach would be a direct in-vivo comparison
of T1 against T2 and T2* as the calibration is now
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